| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |